Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends (NYSE:DGX)

Close up of lab assistant in uniform, with mask and rubber gloves holding test tube with blood sample while sitting on chair and typing on laptop. Selective focus on test tubes.


Quest Diagnostics (NYSE:DGX) recently reported their Q2 earnings with a slight beat on EPS and revenue. Quest’s base business appears to be recovering from the pandemic and pulled in $2.30B in revenue, up 9.5% year-over-year. Although COVID-related revenues

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *